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CHAPTER I
REVIEW OF LITERATURE
Stem cells have been the subject of intense interest and investigation due, in part, to 
their biological properties and potential medical importance (Morrison et al., 1997). 
Unfortunately, it has been exhausting for the nonspecialist to penetrate the area because of 
the difficulty in culturing these delicate cells and, because of the relative challenge in isolating 
these ambiguous cells from the heterogeneous population in which they reside. Stem cells are 
normally ascribed with certain characteristic properties including self-renewal, differentiation 
potential, asymmetric cell division, clonal regeneration of all of the different cell types that 
constitute their host tissue, and they can exist in a quiescent state (Hall and Watt, 1989).
The bone marrow acts as a substratum for functionally discrete stem cells of both 
hematopoietic and nonhematopoietic descent. Hematopoietic stem cells in bone marrow must 
continuously provide a source of progenitors for red cells, monocytes, granulocytes, platelets, 
and lymphocytes. Alternatively, nonhematopoietic stem cells, often referred to as 
mesenchymal stem cells, give rise to adipocytes, fibroblasts, myoblasts, chondrocytes, and 
osteoblasts (Prockop, 1997). In the mid-1970's, Friedenstein e/tz/. (1976) developed a crude 
procedure for separating hematopoietic and nonhematopoietic cells. Friedenstein placed 
samples of whole bone marrow in plastic culture dishes and poured off the nonadherent cells
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after 4 hours. He found that the resultant adherent cells were heterogeneous in appearance 
but, the most tightly adherent cells were spindle-shaped and formed foci of two to four cells 
which remained dormant for 2 to 4 days after which they would multiply rapidly. After 
passage several times in culture, the adherent cells became more uniformly spindle-shaped in 
appearance and would differentiate into colonies that produced small deposits of bone or 
cartilage.
Since the investigations of Friedenstein, most studies on osteogenic marrow stem cells 
have been conducted with the cultures derived from plastic adherence. However, several 
groups of investigators since 1990 have attempted to prepare more homogeneous populations 
of cells (Long et al., 1995, Simmons et al., 1991; Haynesworth et al., 1996; Waller et al.,
1995; Rickard et al., 1996). The use of isolated osteogenic marrow stem cells has several 
advantages: The isolated cells are either clonal or nearly clonal, and they can be induced in 
culture to express large amounts of the same bone markers and to form mineralizing colonies. 
Yet, none of the protocols have yet been used in more than one laboratory, and it has not 
been shown whether they isolate the same cells. Additionally, following isolation, it becomes 
increasingly difficult to culture marrow stem cells since they have effectively been separated 
from the nursing cells which support them, further frustrating the advancement of 
investigations. Such limitations have substantially hindered the progress of studies devoted 
to bone generation and development, or osteogenesis. Furthermore, the fact that bone tissue
consists of a heterogeneous multitude of cells makes the identification of molecular
mechanisms underlying bone growth a noteworthy challenge.
2
Bone is a vital, dynamic connective tissue that plays critical roles in protecting and 
mediating the metabolic pathways associated with mineral homeostasis, and in providing 
structural support for mechanical locomotion (Babe/ al., 1994). Furthermore, it is a primary 
site for hematopoiesis and has been shown to be a component of the immune system 
(Horowitz et al., 1992). Bone formation begins in utero and continues throughout 
adolescence until skeletal maturity. Skeletal development is a multistep process that includes 
patterning of skeletal elements, commitment of mesenchymal cells to the osteogenic and 
chondrogenic lineages, and terminal differentiation of precursor cells into three specialized 
cell types: osteoblasts, osteoclasts, and chondrocytes (Marcus et al., 1996). Embryonic 
development of the skeleton involves two major modes which are distinct in mechanism and
function.
Intramembranous ossification is the characteristic way in which the flat bones of the 
skeleton, such as the bones of the skull and face, are formed. It originates from the branchial 
arches and it involves the direct formation of bone tissue by cells of the mesenchymal lineage 
which have been committed to the formation of osteoblasts (Rodan et al., 1997). 
Mesenchymal cells proliferate and condense into compact nodes after which some cells within 
these nodes develop into capillaries and others into bone forming osteoblasts (Gilbert, 1994). 
Osteoblasts secrete an uncalcified type I collagen-glycosamino-glycan matrix (osteoid) which 
binds the calcium salts that are delivered to the area by the capillaries. As the nodes become 
calcified, the bony spicules radiate out from the center and the entire region becomes 
surrounded by compact mesenchymal cells that develop into the periosteum.
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The appendicular skeleton forms by the process of endochondral ossification. It is 
derived from the somitic mesoderm and it involves the differentiation of mesenchymal cells 
into chondroblasts and then to chondrocytes which synthesize and secrete the proteoglycan- 
rich, type II collagen based extracellular matrix. Thus, cartilage tissue is formed which acts 
as a model for the bone that follows. Endochondral ossification couples chondrogenesis with 
osteogenesis to form the vertebral column and the extremities (Figure 1.1). As mesenchymal 
cells differentiate into chondrocytes, the mesenchymal cells around them develop into the 
periosteum. Upon forming this cartilaginous model, hypertrophic chondrocytes develop in 
the center of the bone and, by secreting more fibronectin and less protease inhibitor, modify 
the extracellular matrix to produce an environment which will permit invasion by blood 
vessels from the periosteum. It has long been thought that as the cartilaginous model was 
degraded, the hypertrophic chondrocytes died, and that the angiogenic response delivered 
osteoblasts which would secrete bone matrix on the partially degraded cartilage. Recent 
ultrastructural evidence indicates, however, that hypertrophic chondrocytes do not die, but 
rather, may transdifferentiate into functional osteoblasts (Hunziker et al., 1987). Intrarenal
transplantation studies of isolated chondrocytes have resulted in bone formation and lend 
proof to the transdifferentiation theory which states that cells expressing a cartilage 
phenotype can change into cells expressing bone-associated markers (Moskalewski et al., 
1989). Striking findings have shown that hypertrophic chondrocytes also express numerous 
markers which are expressed by osteoblasts as well. Some of these include osteopontin, 
osteonectin, alkaline phosphatase (Marcus et al., 1996), bone sialoprotein, and parathyroid 
hormone receptor, among others (Aubin et al., 1995). Thus far, it remains to be determined
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Figure LI The coupled activity of 
chondrogenesis and osteogenesis during 
endochondral ossification.
(Gilbert, 1994)
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whether hypertrophic chondrocytes either transdifferentiate or merely undergo further 
maturational progression into bone-forming osteoblasts.
With time, the ossification front within the cartilaginous model progresses toward the 
ends where the chondrocytes will proliferate prior to undergoing hypertrophy, pushing out 
the ends and, forming the epiphyseal plates (Gilbert, 1994). These epiphyseal plates will form 
the growth area of bone during development. Bone will continue to be added peripherally 
from the internal surface of the periosteum as osteoclasts hollow out the internal region to 
form the bone marrow cavity that will provide a location for further osteogenesis and 
hematopoiesis. At the end of puberty, high levels of estrogen and testosterone will cause the 
remaining epiphyseal plate chondrocytes to hypertrophy, ending elongation (Gilbert, 1994).
Following skeletal maturity, bone continues to remodel throughout life and to adapt 
its structural properties in response to the mechanical demands placed upon it. The structural 
and functional relationships observed in bone, coupled with its role in maintaining mineral 
homeostasis, strongly suggest that it is an organ of optimal structural design (Skedros et al.,
1996).
The basic morphological composition of mature bone consists of a lineage of 
progressively differentiating cells which produce bone and are subsequently incorporated into 
the calcified bone tissue (Nijweide et al., 1986). At the origin of this lineage are 
multipotential mesenchymal cells that undergo a number of restriction steps to give rise to 
progeny with more limited, including monopotential, capacities. These multipotential stem 
cells initially develop into osteoprogenitor cells which are small, undifferentiated cells that 
have already been committed to the osteogenic lineage (Bellows et al., 1989; McCulloch et
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al., 1990; McCulloch et al., 1991). Human osteoprogenitor cells express the STRO-1 antigen 
(GronthoseZa/., 1994; Simmons et al., 1991) and are found both within the periosteum and 
within cell colonies in the bone marrow along with hematopoietic cells (Prockop, 1997; Van 
Vlasselaer et al., 1994; Mizuno et al., 1997). Osteoprogenitors are eventually induced to 
differentiate into osteoblasts following the influence of paracrine growth factors (Long et al., 
1995; Lippiello et al., 1992; Amedee et al., 1994; Quarto et al., 1995) and hormones of the 
endocrine system (Marcus et al., 1996). Some of the growth factors believed to be involved
are Transforming Growth Factor 3 (TGF-P)(Takeuchi etal., 1996;Raynale/a/., 1994),basic
fibroblast growth factor (bFGF)(Long etal., 1995), Prostaglandin-E2 (PGE2)(Centrella etal.,
1994), and Insulin-like growth factor (IGF)(Gilbert et al., 1994). These chemical factors 
activate signal transduction pathways which result in the differentiation of osteoprogenitors 
into bone-forming osteoblasts.
Osteoblasts adhere to the surface of bone and secrete osteoid by aposition, which is 
the deposition of bone over a pre-existing bone surface (Figure 1.2). Osteoblasts are the only 
cells within the osteogenic lineage to express the enzyme alkaline phosphatase on their 
surface (Harris etal., 1995; Nefussi etal., 1997). Although the exact function of this enzyme 
is unknown, it is believed to be responsible for hydrolyzing pyrophosphate into inorganic 
phosphate which is further utilized to make calcium crystals (hydroxyapatite) (Haynesworth 
et al., 1992). Hydroxyapatite is then deposited into the osteoid to give bone its 
characteristically rigid structure.
In vivo, some osteoblasts eventually become embedded within their own secretions 
wherein they lose their proliferative potential and decrease their metabolic activity. At this
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point, the cell becomes known as the osteocyte, which is a cell with stellar morphology and 
represents the final differentiated state of the osteogenic lineage (Yamaguchi et al., 1994). 
Although imprisoned within the hard bone matrix, osteocytes remain connected with other 
osteocytes and osteoblasts via cytoplasmic projections found within canaliculli networks (Van 
Der Plas et al., 1994) (Figure 1.2). Since osteocytes reside within hard bone matrix, it is 
believed that they are directly subjected to the mechanical loading which affects the skeleton. 
Due to this fact, it is believed that osteocytes are responsible for transducing mechanical 
stimuli into a more sustained cellular response (Skedros et al., 1996; Lozupone et al., 1996). 
This phenomenon might occur via an autoamplification system whereby osteocytes 
recognize physical stress and respond by secreting factors which in turn relay the local 
remodeling command (Van Der Plas et al., 1994).
Recent investigations have shown that osteocytes are some of the most 
mechanosensitive cells in bone. Forwood et al. (1996) have shown that a single episode of 
dynamic loading on bone with a magnitude of 65 Newtons increased bone formation rate 
and was maximal 5-8 days post loading. Weinbaum et al. (1994) found that high frequency, 
low amplitude postural strains on bone can maintain, and even increase, bone mass. They 
state that the proteoglycan filled fluid annuli that surrounds the osteocytic processes within 
the canaliculli could be stimulated by small fluid shear stresses. This supports the current 
hypothesis that stress on bone causes the flow of fluid through the osteocytic canaliculli 
network which in turn stimulates these cells to produce paracrine factors that regulate bone
metabolism (Weinbaum etal., 1994; Van Der Plas et al., 1994).
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Figure 1.2. Schematic representation of bone formation by aposition 
(Alberts et al., 1994)
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Klein-Nulend et al. (1995a, 1995b) have provided evidence that osteocytes react to 
pulsating fluid flow with a rapid and transient stimulation of Nitric Oxide (NO) release which 
leads to an enhanced and prolonged prostaglandin (PG) E2 release. Studies run by Centrella 
et al. (1994) indicate that PGE2 has direct regulatory effects on the biochemical activities of 
discrete bone cell populations. They found that more differentiated bone cells could activate 
and recruit less differentiated cells, by way of PGE2 production, and that these less 
differentiated cells enhanced bone repair that results from cytokines released during the 
inflammatory process.
Remodeling would not be complete without a cell specialized in degrading the pre­
existing bone matrix. Osteoclasts are giant, polynucleated cells of the hematopoietic lineage 
which are essential for executing the remodeling response. Via osteoclastogenesis, 
osteoclasts arise by the fusion of monocyte/macrophage precursors whose development is 
regulated by a group of cytokines (Marcus et al., 1996). Interleukin (IL) 1, IL-3, IL-6, 
erythropoietin, epidermal growth factor, and bFGF, among others, have been shown to be 
required for optimal differentiation of the hematopoietic stem cell to the committed osteoclast 
precursor (Marcus etal., 1996). Mature osteoclasts secrete acids and enzymes responsible 
for the breakdown of bone. Bicarbonate, generated by carbonic anhydrase activity, is 
responsible for dissolving the bone minerals (Blair et al., 1986). Meanwhile, acid 
phosphatases and collagenolytic cysteine-proteinases found within vessels destined for 
exocytosis in the apical ruffled border of the osteoclast, are essential for digesting the organic 
component of bone (Chambers et al., 1985). Together, osteoblasts and osteoclasts work 
cooperatively in a delicate balance between bone deposition and bone resorption.
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The past few years have provided insights which have led to the realization that 
endocrine and paracrine influences on bone remodeling are not mutually exclusive. Hormones 
from the endocrine system have been strongly implicated in mediating bone metabolism. In 
adult women, estrogen plays a critical role in maintaining bone mass by exerting a tonic 
suppression of cancellous bone remodeling and maintaining remodeling balance between 
osteoclastic and osteoblastic activity (Jagger et al., 1996). A remodeling imbalance results 
from estrogen deficiencies which leads to increased osteoclastic activity at the expense of 
impaired osteoblastic activity. Thus, the increase in osteoclastic excavation without the 
concomitant increase in osteoblastic deposition has been implicated in the high incidence of 
osteoporosis in post-menopausal women (Wronski et al., 1993).
Parathyroid hormone (PTH) is synthesized in the parathyroid glands in a highly 
sensitive response to a falling extracellular ionized calcium activity. A fall in calcium is 
detected by a calcium sensor which is a G-protein-linked cell surface protein (Marcus et al., 
1996). Messenger RNA for the receptor is most abundantly found in the parathyroid glands, 
but is also found in the kidneys and in the thyroid gland where the hormone might mediate 
the Ca2+-sensitive secretion of calcitonin from the thyroid C-cells.
Parathyroid hormone increases the number and activity of osteoclasts in bone. It 
induces osteoclasts to mobilize and degrade the bone matrix and, by doing so, raises 
circulating levels of Ca2+ (Holtrop et al., 1979). However, PTH receptors have not been
demonstrated on osteoclasts and there is no evidence that the hormone exerts a direct
biological effect on isolated osteoclasts (Marcus et al., 1996). Osteoblasts and their 
precursors are sensitive to the hormone and may serve as intermediaries in PTH-mediated,
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osteoclastic bone resorption by secreting paracrine factors which directly stimulate
osteoclasts.
Calcitonin, synthesized and secreted by the thyroid gland in response to high 
circulating levels of Ca2+ (Miyauchi et al., 1990), dampens bone resorption by directly 
targeting osteoclasts. Calcitonin binding sites are, in fact, the only peptide hormone receptors 
unequivocally resident on osteoclasts. Osteoclast exposure to calcitonin is followed by an 
increase in intracellular Ca2+ activity and generation of cyclic AMP (Marcus et al., 1996). 
Within seconds, osteoclasts contract and become immobile due to changes in the microtubule 
and microfilament arrangements within the cytoskeleton. Thus, calcitonin and parathyroid 
hormone act by opposing each other through a system of checks and balances to mediate and
control mineral homeostasis.
Along with endocrine and paracrine signals, autocrine factors are critical for mediating 
and maintaining bone metabolism. Nitric Oxide (NO) has not only been shown to be an 
important autocrine factor involved in the osteocytic response to mechanical stress, but it 
dramatically alters osteoclastic bone resorption as well (Marcus et al., 1996). NO is located
in the ruffled membrane and is induced when osteoclasts contact the skeletal matrix. NO is
produced by osteoclasts via NO synthase and directly targets the osteoclast itself. 
Interestingly, NO inhibits osteoclast spreading (Holtrop et al., 1991). Thus, it acts much like 
calcitonin in inhibiting bone resorption (Marcus et al., 1996).
Recently, various novel growth factors have been discovered which appear to play 
crucial roles in bone development and maintenance. Genes encoding for the bone 
morphogenic proteins (BMPs) are critical during morphogenesis and body axis determination
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(Gilbert et al., 1994). During embryonic limb development in mice, BMPs are expressed at 
sites of cartilage and bone development (Robey et al., 1985). These BMP’s, in turn, 
participate in the signaling cascade required for limb morphogenesis.
Core-binding factor 1 (Cbfal), which belongs to the rwnZ-domain gene family, is 
restrictively expressed during fetal development (Mundlos et al., 1997). In mammals, three 
r//A7/-domain genes have been found (Cbfal/Pebp2aA, Cbfa2/Pebp2aB, and Cbfa3/Pebp2aC) 
which contain a 128 amino acid-long DNA binding domain, runt, which is homologous with 
the Drosophila melanogaster pair-rule gene runt (Komori et al., 1997; Ducy et al., 1997). 
They form heterodimers with the cotranscription factor Cbfb/Pebp2b and their 
heterodimerization is required for their DNA-binding capacity in vitro (Ducy et al., 1997). 
Data reviewed so far strongly suggest that Cbfal is an essential transcription factor required 
for bone formation and, more specifically, for osteoblast differentiation (Ducy et al., 1997).
Komori et al. (1997)deleted the Cbfal gene in mice by homologous recombination. 
The homozygous Cbfal'7' mice died soon after delivery due to an inability to breathe. Upon 
detailed analysis, it was found that the mice completely lacked the intramembranous bones
of the skull and the endochondral bone in the rest of the skeleton. Histochemical analysis of
the Cbfa'' mice has shown that osteoblasts are absent and that osteoclasts are smaller than
normal (Otto et al., 1997).
Cbfal may regulate expression of early markers for osteoblast differentiation, as well
as osteocalcin expression. Cbfal stimulates osteoblast-specific transcription of the
osteocalcin gene via the osteoblast-specific c/.s-acting element, OSE2, in the osteocalcin
promoter (Geoffroy et al., 1998). Osteocalcin is the only gene to be expressed in osteoblasts
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and in no other extracellular matrix-producing cell type (Towler et al., 1994; Ducy et al., 
1996). The human osteocalcin gene is localized on chromosome 1 and it is approximately 1.2 
kb with four exons that predict a 125 amino acid-long protein (Marcus et al., 1996). Due to 
the highly specific nature of osteocalcin expression, its promoter has been intensely 
scrutinized and investigations have led to the characterization of the “osteocalcin box”. The 
osteocalcin box contains a binding site for Msx-1 and Msx-2 (homeodomain proteins) which 
have been found to be synthesized by osteoblastic cells (Marcus et al., 1996).
Osteocalcin is made by osteoblasts and it is considered to be a marker of osteoblastic
function as well as a coupler for the osteoblast-osteoclast interaction during remodeling 
(Marcus et al., 1996). It has also been shown to be an important factor for the induction of 
the osteoclastic phenotype. Since osteocalcin has a high and relatively specific affinity for 
apatite, it has been proposed as a specific regulator of the length of the mineral crystals in 
bone (Kesterson et al., 1993). Furthermore, osteocalcin has been reported to be involved in 
osteoclast recruitment. Investigations on osteocalcin’s function have shown that osteocalcin- 
deficient bone particles are not readily resorbed (Ducy et al., 1995). Though recent analysis 
supports the role of osteocalcin in regulating bone growth in vivo, further studies are required 
before its effects on osteoblasts, osteocytes, and osteoclasts can be verified.
Although many aspects of mature osteoblast function have been clarified in recent 
years, there is little information about the regulation of the early stages of osteoprogenitor 
differentiation. A primary limitation to these studies has been the difficulty in identifying and 
establishing an unambiguous and homogeneous population of osteoprogenitor cells. 
Complicating the situation is the fact that, upon isolation, these primary precursor cells are
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fragile and not very permissive to many of the standard manipulation protocols employed in 
cellular and molecular biology. In attempt to delineate the regulatory mechanisms that 
mediate osteoprogenitor differentiation, several model systems have been developed (Hicok 
etal., 1998; Jaenisch etal., 1988; No et al., 1996). Some of these model systems have been 
obtained from cell lines derived from malignant bone or bone marrow tumors yet, although 
important information has been obtained with these systems, the malignant transformations 
usually alter the molecular and cellular phenotypes substantially.
The aforementioned cell lines are all employed in hopes that some of the fundamental 
mechanisms underlying normal osteogenesis may be determined, however, the abnormalities 
incurred by such malignant transformations preclude full confidence that results resemble the 
characteristics of wild type osteoprogenitor cells. An invaluable tool for studying 
development and other physiological processes is the precise control of cell proliferation and 
differentiation. Therefore, the establishment of a conditionally immortalized cell line of 
osteoprogenitor cells would greatly enhance the ability to study stage-specific cellular 
interactions and paracrine regulation of osteogenesis (Hofmann et al., 1992). No et al. 
(1996) have recently established a system allowing the conditional induction of specific genes 
with the insect molting hormone ecdysone. The steroid hormone ecdysone has been shown 
to trigger metamorphosis in Drosophila and its genomic effects were detected, in part, as 
influencing chromosomal puffing within minutes of hormone addition. A benefit for 
transferring ecdysone responsiveness to mammalian cells is that it takes advantage of a 
naturally evolved steroid-inducible system whose lipophilic compounds enable efficient 
penetration into all tissues (No et al., 1996). Ecdysteroids have short half-lives and favorable
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pharmacokinetics which expedite clearance and prevent storage. Additionally, the fact that 
they are neither toxic, teratogenic, nor known to affect mammalian physiology, make them
ideal reagents for use in conditionally immortalized cultured cells.
In the first part of this study we intend to develop a means for extracting osteogenic- 
specific cells (osteoprogenitors, osteoblasts, and osteocytes) from mice, establishing suitable 
culturing conditions for these cells, and characterizing the developmental stages down the 
osteogenic lineage. In the second part, we propose a highly efficient technique for isolating 
human osteoprogenitor cells from femoral bone marrow by using the STRO-1 antibody 
(Developmental Studies Hybridoma Bank) conjugated with magnetic beads. We also offer 
conclusive evidence that osteoprogenitors reside within the STRO-1 positive cell fraction of 
the human bone marrow and we indicate species-specific differences between human and
mouse osteoprogenitors. Furthermore, we attempt to conditionally immortalize human 
osteoprogenitor cells by introducing the ecdysone-inducible expression system employing the 
transfection techniques of calcium-phosphate precipitation and electroporation.
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CHAPTER II
Isolation and Characterization of Murine Osteogenic Cells
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ABSTRACT
Femoral bone cells from adult female mice were isolated and fractionated into 3
discrete cell populations that represent the various stages of the osteogenic lineage. Upon 
separation and cultivation, osteoprogenitors, osteoblasts, and osteocytes were monitored and 
characterized for distinct morphological differences. Further in vitro characterization of 
differentiation was evaluated by following the sequential expression of the membrane-bound 
enzyme alkaline phosphatase. Although specific surface markers have not been identified for 
murine osteoprogenitors, it is known that they reside within the adherent, low-density (ALD) 
cell fraction of the bone marrow stroma. These alkaline phosphatase negative, small (~10 
//m), round cells are highly proliferative, forming clusters (<50 cells) and colonies (>50 cells) 
before spreading and differentiating into alkaline phosphatase positive osteoblasts and 
radiating outward from the central cell aggregates.
Homogeneous cultures of osteoblasts and osteocytes were established by sequential 
digestion of calcified bone tissue with collagenase followed by separation with an anti-alkaline 
phosphatase monoclonal antibody. Both cell types regained their distinctive morphology 
within 2-3 days post extraction. In fact, osteocytes assumed their characteristic stellate 
morphology and extended thin cytoplasmic projections toward each other suggestive of those
situated within canaliculli networks in calcified bone.
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INTRODUCTION
In mammals, it is generally accepted that osteogenesis proceeds by fundamentally 
common mechanisms. In fact, most research on osteogenesis and bone remodeling has been 
conducted using murine models and the results are believed to be representative and indicative 
of human osteogenesis. Many investigations have already characterized a formal series of 
stages through which an osteogenic cell must pass as it progresses down the osteogenic 
lineage. As with all other mammals, murine osteogenesis begins with the osteoprogenitor 
stem cell, proceeds into the functional osteoblast cell, and concludes at the terminally 
differentiated osteocyte. Although a few of the genes involved in this process have been 
discovered, most have yet to be identified.
A major impedance to the in vitro study of osteogenesis is the difficulty in establishing 
separate and morphologically distinct osteogenic cell cultures from the heterogeneous 
population found within bone and bone marrow. In this study, we propose a series of 
techniques for extracting and isolating osteoprogenitors, osteoblasts, and osteocytes from 
mouse femoral marrow and calcified bone tissue. Furthermore, we have characterized the 
discrete morphological stages of the osteogenic cell lineage and report some striking species- 
specific differences between murine and human osteoprogenitor differentiation.
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MATERIALS AND METHODS
Isolation and Cultivation of Osteoprogenitor Cells
Bone marrow stromal cells were isolated from the femurs of 2-month-old female
BALB/c mice. Briefly, femurs were excised aseptically and the ends of the bones were 
removed. The bone marrow was flushed out using 5 mL of Phosphate Buffered Saline (PBS, 
pH 7.2) through a 21 gauge needle attached to a 5 mL syringe. The released cells were 
dispersed into a single-cell suspension and aliquoted into two 13x100 mm sterile tubes 
containing anhydrous EDTA (10.5 mg Na2) (Terumo Venoject). The contents were shaken 
briefly, transferred into two disposable, sterile 15 mL centrifuge tubes (Fisherbrand, Florence, 
KY), and centrifuged at 300 x g for 10 minutes at 20°C. The supernatant was discarded and 
cells were resuspended in 5 mL of Dulbecco’s modified Eagle medium (D-MEM) 
supplemented with 10% fetal calf serum (FCS), 1 mM sodium pyruvate, 2 mM glutamine, 
50 U/ml penicillin, 50 pg/ml streptomycin and 100 pM non-essential amino acids (all
reagents purchased from Atlanta Biologicals, Norcross, GA)(from now on referred to as 
complete medium). Next, the cell suspensions were subjected to equilibrium-density 
centrifugation (density=1.086±0.001g/mL @ 20°C)(Ficoll; Atlanta Biologicals, Norcross, 
GA) and the resultant mononuclear, low-density cells (i.e., those cells present at the Ficoll- 
medium interface) were counted with a hemocytometer and treated to 4 hours of plastic
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adherence to remove nonadherent cells. The final concentration of adherent cells was
determined by subtracting the number of nonadherent cells from the total mononuclear, low- 
density cell concentration. The resultant adherent cells were cultivated on 35 mm dishes, 4 
mm wells, and in 16 mm wells either on plastic, on a thin coating of solidified rat tail type I 
collagen at 5 pg per cm2, or within 12% type I collagen gel. Cultures were incubated in the 
presence of complete culture medium at 37 °C in 5% CO2.
Extraction and Isolation of Osteoblasts and Osteocytes
Femurs were obtained aseptically as described above, flushed with PBS to remove 
marrow, and dissected free of periostea. The calcified tissue was minced and a mixture of 
osteoblasts and osteocytes was extracted by sequential collagenase (Life Technologies, Grand 
Island, NY) digestion. Briefly, minced bone was incubated in collagenase at a final 
concentration of 2 mg/mL in PBS at 37°C for intervals of 1,2,4, and 8 hours (respectively 
called OCY I, II, III, and IV) with agitation every 30 minutes. Following each digestion 
interval, the supernatant was collected, centrifuged at 300 x g for 15 minutes at 20°C, 
resuspended in serum-free medium, and the cells were seeded (at a concentration of 2.5-6.5 
x 105 cells/cm2) for one hour onto 35mm dishes coated with the alkaline phosphatase-specific 
MAb, B4-50 (lOpg/mL) (Mayo Clinic, Rochester, MN) and rotated gently every 15 minutes. 
Nonadherent osteocytes and immune adherent osteoblasts were separated and cultivated in 
complete culture medium at 37°C in 5% CO2.
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Alkaline Phosphatase Activity
Osteogenic differentiation was assessed by the alkaline phosphatase chromogenic reaction 
(Narisawa et al., 1990). Cells were fixed on days 3, 5, 8, 10 and 14 with 10% formalin in
PBS for 10 minutes at +4°C. The cells were then washed two times with 0.2AY Tris buffer,
pH 8.9. The reaction mixture, prepared fresh, consisted of 0.1% napthol AS-MX phosphate 
(Sigma BioSciences, St.Louis, MO) and 0.3% fast violet B salt (Sigma BioSciences, St.Louis, 
MO) in 0. LA/ Tris buffer, pH 8.9. The fixed cells were incubated in the presence of the 
reaction mixture for 30-40 minutes at 37°C then viewed under a brightfield microscope (IMT- 
2 Olympus inverted research microscope)
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RESULTS
Osteoprogenitor Cells
Adherent, low-density cultures consisted of small (~10/zm), round cells that 
proliferated rapidly immediately following extraction. Within 3 days post-extraction, the 
isolated cells proliferated into patches, or clusters (10-50 cells), which further developed into 
large colonies (>50 cells) in a matter of 5-7 days. Furthermore, within a week of cultivation, 
the cells began to differentiate into spread and elongated, alkaline phosphatase positive cells 
which radiated out from the central cell aggregates (Figure II.la and b). Figure II.2 
represents the data gathered from four trials run in duplicates throughout a two week time 
span each of the differentiation of putative osteoprogenitors into osteoblast-like cells.
Putative osteoprogenitors cultivated on 4 mm wells, 16 mm wells, and 35 mm dishes 
displayed different degrees of colony-forming efficiency with greater levels of cell division 
being detected as the surface area of the culture flasks increased. In fact, neither colony­
forming efficiency nor differentiation were detected at all in the 4mm wells. Furthermore, 
both alkaline phosphatase activity and differentiation occurred nearly twice as quickly in the 
35 mm dishes as opposed to the 16mm wells (7days vs. 14+days for maximal differentiation, 
respectively).
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Figure II.l. a. Aspects of small osteoprogenitor clusters in the process of differentiating into 
alkaline phosphatase positive cells (stained red) after 7 days in culture. Original xl50. b. 
Fully mature alkaline phosphatase positive osteoblasts after 14 days in culture. Original x
200.
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Proliferation Rate of Alkaline Phosphatase 
Positive Osteoblasts
Figure H.2. Data gathered over a period of two weeks for the 
proliferation rate of differentiated adherent low-density cells on plastic.
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Osteoprogenitors seeded onto a thin coating of solidified type I collagen displayed the 
same behavior as cells plated on plastic surfaces. Neither variations in proliferation nor 
differentiation were observed between the two culture conditions. However, cells cultivated 
in 12% type I collagen gel lost all proliferative and differentiative potential. Interestingly, 
when these osteoprogenitors could avoid the collagen gel by becoming situated on a collagen- 
free surface, they reacquired their characteristic behavior patterns to form clusters.
From all of the trials in which differentiation ensued it became evident that mouse
osteoprogenitors follow the central dogma of cell development in which cells are believed to 
proliferate first, then differentiate. Accordingly, alkaline phosphatase expression was detected 
at low activity only after the osteoprogenitors began spreading and elongating into osteoblast­
like morphology. Alkaline phosphatase activity could be detected as early as day 5 post­
extraction and increased gradually until it began to decline again after about 12 days post­
extraction. Following the decline in alkaline phosphatase activity, cells would lose some of 
the characteristic osteoblast morphology and some cells would die. However, most cells 
simply seemed to enter the Go phase of the cell cycle.
Osteoblasts and Osteocytes
Immune adherence produced pure cultures of osteoblasts which displayed maximal 
levels of alkaline phosphatase activity. Within 24 hours post-extraction, osteoblasts began 
to resume their natural morphology by spreading and proliferating. Osteoblasts were 
monitored and subcultured for 1 month post-extraction. Alkaline phosphatase activity 
persisted for the first 2 weeks post-extraction but began to subside between weeks 2 and 3.
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Purified osteoblast degeneration resembled that observed for the osteoblasts produced from 
the osteoprogenitor trials in which cell death and quiescence resulted from prolonged tissue 
culturing.
Similarly, isolated osteocytes resumed their natural, stellate morphology within 24 
hours post-extraction (Figure II.3a and b). Shortly following extraction, osteocytes extended 
cytoplasmic projections toward each other reminiscent of the networks found within bone 
canaliculli. As expected, longer periods of collagenase digestion yielded greater percentages 
of osteocytes with a concomitant decrease in osteoblast numbers. These results produced 
nearly pure cultures of osteocytes within the OCY IV digestion intervals. These pure 
osteocyte cultures retained their characteristic stellate morphology for 10 days after which 
their cytoplasmic projections would shorten and lose some of their discrete borders and 
edges.
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/L
Figure II.3. a. Femoral bone cells after 4 hours digestion with collagenase I and following 
10 days in culture. Stellar-shaped osteocytes are seen extending cytoplasmic projections 
toward alkaline phosphatase positive osteoblasts. Original x 300. b. Isolated osteocytes after 
12 hours digestion with collagenase I and removal of osteoblasts with the monoclonal 
antibody, B4-50. Neighboring osteocytes are seen connected by cytoplasmic bridges. 
Original x 400.
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DISCUSSION
It has been reported previously that osteoprogenitor cells reside within the 
nonadherent, low-density subpopulation of the bone marrow (Long et al., 1995). Our 
analysis indicates, however, that the adherent, low-density cell fraction of the bone marrow 
displayed characteristics expected of osteoprogenitor cells. Cultivated adherent cells initially 
appeared small and round yet proliferated rapidly then differentiated into osteoblast-like, 
alkaline phosphatase positive colonies. Furthermore, other researchers claim that 
osteoprogenitors require the administration of essential factors such as dexamethasone and 
type I collagen in order to differentiate into functional osteoblasts in vivo (Mizuno et al., 
1997). We found otherwise. None of our cultures were dependent on factors other than the 
ones found within our complete culture medium in order to develop into monolayers of 
osteoblasts. It remains to be determined, however, whether factors present within our 
medium may have driven osteoprogenitor differentiation. That is, the particular type of fetal 
calf serum used in our studies may contain essential factors which were not present in other 
investigations.
Additionally, osteoprogenitors embedded within 12% collagen gel lost all proliferative 
and differentiative potential and those cultured over a thin layer of solidified collagen did not 
display elevated activity levels when compared to cells maintained on plastic alone. The fact
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that collagen gel coating inhibited osteoprogenitor cellular activity would be expected since 
it would be unnecessary for an osteogenic stem cell to expend energy and differentiate into 
a bone forming osteoblast in the presence of a preexisting three-dimensional bone matrix. In 
other words, when found in excess, collagen may act as a growth inhibitor for 
osteoprogenitors since the presence of this protein would indicate adequate bone production. 
Alternatively, the normal resulting activity by osteoprogenitors seeded onto a thin layer of 
solidified collagen would also make intuitive sense since an open, one-dimensional layering 
of collagen would simply be translated as a bone surface which is devoid of, and in need of,
osteoblasts.
Osteoprogenitors grown on different size culture flasks exhibited greater degrees of 
proliferation and differentiation with increasing surface area. Although no minimal cell 
concentration threshold required for optimal cell division and differentiation could be 
determined conclusively, it was apparent that the inherent differences in cellular activity could 
be attributed to cell numbers (mean cell density for 16mm wells was 2 x 105cells/cm2 as 
opposed to 6 x 104cells/cm2 for 35mm dishes however, overall, 35mm dishes contained more 
cells than 16mm wells). It appears as if when plated at decreasing concentrations in 
accordance with a smaller surface area, osteoprogenitors lose their capacity for growth. A 
decrease in cell numbers may result in the decrease of a secreted growth factor by other 
stromal cells which, when present at a critical concentration, induces osteoprogenitor 
proliferation and differentiation.
Results from the osteocyte and osteoblast extraction experiments produced purified 
cultures which can be used to further study the mechanical induction of bone remodeling. As
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expected, longer digestion intervals resulted in greater concentrations of osteocytes with a 
concomitant decrease in osteoblasts since osteocytes are situated further into the calcified 
bone tissue within lacunae. Thus, all three cells types have been extracted successfully and 
have been made available for further experimentation. Worth mentioning is the fact that, 
although plastic adherence provided us with a bone marrow cell subtype which was capable 
of differentiating into functional osteoblasts, a pure culture of mouse osteoprogenitors cannot 
be prepared by this method alone. Despite our efforts to remove nonadherent, high-density 
cells, the resultant osteoprogenitor cultures consisted of heterogeneous populations of bone 
marrow-specific cells. Further modification of the protocols would have to be made before 
a truly purified culture could be produced. Specifically, pure cultures would be difficult to 
achieve unless a surface marker for murine osteoprogenitors is discovered and an antibody 
is generated against it.
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CHAPTER HI
Immunomagnetic Isolation of Osteoprogenitors from Human 
Bone Marrow Stroma
Work supported by: Ohio Board of Regents Research Challenge Program 
and Sigma Xi, The Scientific Research Society
32
ABSTRACT
We report her the efficient isolation of human bone marrow osteoprogenitors using 
magnetic beads coated with a mouse monoclonal antibody recognizing the STRO-1 antigen 
(Simmons etal., 1991). Osteoprogenitors accounted for 100% of the STRO-1 positive cell 
population. Upon long term culture, osteoprogenitors differentiated down the osteoblastic 
lineage as evidenced by their increased expression of alkaline phosphatase and their 
production of osteocalcin. Human osteoprogenitors assumed a spread morphology in tissue 
culture. Upon differentiation, they first expressed alkaline phosphatase on their surface before 
they began proliferating as phenotypically recognizable osteoblasts. This observation conflicts 
with previous studies that have characterized human osteoprogenitors as highly proliferative 
cells that form colonies prior to differentiating into osteoblasts (Long etal., 1995). The ability 
to isolate human osteoprogenitors with high efficiency will substantially advance 
investigations on osteogenesis and bone remodeling.
Key words: osteoprogenitor, human, isolation, magnetic beads, differentiation
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INTRODUCTION
The proteins present in the bone extracellular matrix (ECM) are synthesized by 
osteoblasts, which are cells of mesenchymal origin. Osteoblasts produce the type I collagen- 
glycosaminoglycan (GAG) matrix in which they are subsequently incorporated. Beside 
collagen type I and GAG, osteoblasts produce osteocalcin, a protein which is not secreted by 
any other ECM-synthesizing cell type (Towler et al., 1994; Ducy et al., 1995). Expression 
of osteocalcin is under control of Cbfa-1, a transcription factor belonging to the Cbfa family 
of proteins, which are homologs of Runt, a Drosophila pair-rule gene product (Gergen etal., 
1985; Ducy eta/., 1997; Komori etal., 1997; Otto eta/., 1997). Osteoblasts also express the
membrane-bound enzyme alkaline phosphatase at high levels (Herbertson et al., 1997).
Although much has been learned in recent years about the regulation of differentiation 
in mature osteoblasts, there is less information about the regulation of earlier stages of cell 
differentiation within the osteoblastic lineage. It is now generally accepted that osteoblasts 
arise by differentiation from multipotential progenitor cells within the bone marrow stroma 
that also are capable of committing to other mesenchymal lineages, including fibroblasts,
myoblasts, chondrocytes, and adipocytes (Aubin et al., 1993; Triffit etal., 1996; Owen c/a/.,
1988). However, progress in understanding the direct precursors of osteoblasts, the
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osteoprogenitors, has been hampered by the small number of molecular markers available
(Aubineta/., 1996).
Several in vitro systems have been developed in order to understand the cellular and 
molecular mechanisms regulating osteoprogenitors and osteoblasts differentiation. Initially, 
osteoblast-derived cell lines were obtained from malignant bone tumors. However, due to 
their irreversibly transformed phenotype, these cell lines cannot be used to study normal 
osteoblast differentiation (Hassager et al., 1992; Okazaki et al., 1995). Mouse bone marrow 
stromal cell lines have also been established, which exhibit different phenotypes and 
differentiation potential down the osteoblastic lineage (Benayahu et al., 1991; Fried et al., 
1996). However, it is unclear whether the stages of differentiation in these cell lines 
correspond exactly to those of human osteoblast differentiation. Recently, stable transfections 
of immortalizing, non-transforming genes such as the Simian Virus 40 Large T antigen (S V40 
LTAg), the polyoma virus LTAg gene, or the adenovirus El A gene have been used to 
facilitate the production of cell lines from various mouse and human somatic tissues (Linder 
et al., 1990; Spelsberg et al., 1995). However, a problem associated with the introduction of 
immortalizing genes into cells is that these genes can alter normal cellular morphology and 
physiology (Brinster et al., 1984; Ridley et al., 1988). This problem theoretically can be 
overcome by using mutant conditional immortalizing genes. The technique allows the 
generation of continuously proliferating cell lines capable of differentiation after inactivation 
of the immortalizing gene. For example, the SV40 mutant temperature-sensitive (ts) gene 
tsA58 has been used in the generation of a variety of conditionally immortal somatic cell lines 
(Jate/cz/., 1989, 1991; Chambers etal., 1993; Morgan et al., 1994; Okuyama 1995)
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including mouse and human osteoprogenitors (Dennis et al., 1996; Hicok et al., 1998).
However, upon long-term culture, these cells may not conserve their ability to differentiate.
This may be due to cumulative changes induced by the Large T antigen over time, that
prohibit reversal of cellular immortalization, as shown recently in other systems (Ewald et al.,
1996).
Another model system employs primary human or rodent bone marrow stromal cells 
isolated by density gradient separation followed by plastic adherence (Friedenstein, 1976). 
The non-adherent fraction of marrow stromal cells has also been studied (Long et al., 1995).
In all cases, some of the isolated stromal cells were able to differentiate into osteoblasts.
However, bone marrow consists of a contiguous population of phenotypically and 
functionally diverse cell groups that collectively regulate and support hematopoiesis and 
osteogenesis. A network of adipocytes, endothelial cells and macrophages coexists intimately 
with cells responsible for maintaining the mechanical identity of the calcified bone tissue. The
osteoprogenitor concentration in bone marrow has been estimated at one cell in one hundred
thousand (Haynesworth e/ al., 1992; Rickard et al., 1996; Cheng et al., 1994, Kasseme/a/., 
1991). Thus, due to the diversity of the stromal elements, an inability to identify an 
unambiguous and homogenous population of osteoprogenitors has considerably hindered the 
progress of scientific investigation.
Furthermore, studies have shown that the STRO-1 positive fraction of the human 
bone marrow consists of cells capable of forming mineralized matrix and producing the bone- 
specific protein osteocalcin (Gronthos et al., 1994). However, the claim that the STRO-1 
positive subpopulation of the human bone marrow has not been universally accepted as
36
containing the osteoprogenitor stem cell. Further investigations have to be conducted in 
order to confidently assure that the STRO-1 antigen is undeniably expressed on human bone 
marrow osteoprogenitor cells.
In the present study, we report a highly efficient method for extracting and isolating 
human bone marrow osteoprogenitors, using density gradient centrifugation and a specific 
antibody conjugated to magnetic beads . The antibody is known to recognize an surface 
antigen, STRO-1, expressed by a subset of human bone marrow stromal cells (Simmons et 
al., 1991). After a period of culture of 21 days, the isolated putative osteoprogenitors 
differentiated down the osteoblastic lineage as evidenced by their strong alkaline phosphatase 
activity and their production of the osteoblast-specific protein, osteocalcin.
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MATERIALS AND METHODS
Human subjects:
Samples of trabecular bone were obtained aseptically from the hip of 40 human 
volunteers during joint replacement surgery. Samples were collected at Miami Valley 
Hospital, Dayton, OH, during a period of one year, and after the subjects’ informed consent.
Isolation of bone marrow mononucleated cells:
Immediately following surgery, the bone samples were placed in 10 ml Dulbecco’s 
modified Eagle medium (D-MEM) supplemented with 10% fetal calf serum (FCS), 1 mM 
sodium pyruvate, 2 mM glutamine, 50 U/ml penicillin, 50 pg/ml streptomycin and 100 pM 
non-essential amino acids. The samples were finely minced with scissors. Remaining bone 
fragments were removed by passing the suspension through sterilized gauze. The resulting 
cell suspension was centrifuged at 200 x g, washed once with phosphate-buffered saline (PBS, 
pH 7.2) and resuspended in 10 ml of supplemented D-MEM. To isolate mononucleated cells, 
the cell suspension was carefully layered on top of 10 ml of a Ficoll solution 
(density=l ,086±0.001g/mL @ 20°C) and centrifuged at 400 x g for 30 minutes at 20°C. The 
mononucleated cells were recovered from the medium-Ficoll interphase, resuspended in 2 ml
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of supplemented D-MEM and proceeded for immunopurification. All reagents were 
purchased from Atlanta Biologicals, Atlanta, GA.
Preparation of magnetic beads/antibody conjugates.
Dynabeads M-450 (Dynal, Lake Success, NY) were washed and coated with the
mouse monoclonal anti-STRO-1 antibody (University of Iowa Hybridoma Bank) (Simmons
etal., 1991) essentially according to the manufacturer’s instructions. Briefly, 5 pg of STRO- 
1 antibody were added to 107 Dynabeads in a final volume of lOOpL of 0.5M Borate buffer, 
pH 8.0, and mixed gently by pipetting. The mixture was placed in a 15 ml sterile centrifuge
tube (Fisherbrand, Florence, KY) and incubated for 24 h at 4°C on a rotary shaker (190
strokes/min). Following incubation, the coated beads were placed in a magnet (Dynal MPC- 
10) for 60 seconds and drained of the supernatant. They were washed twice for 5 minutes at
4°C, then overnight at 4°C, using a rotary shaker. As a washing buffer, we used PBS
supplemented with BSA (100 mg/ml), pH 7.4. Chemicals were purchased from Sigma, St
Louis, MO.
Immunomagnetic isolation of human osteoprogenitors '.
Antibody-conjugated Dynabeads were added directly to the cell samples at a final
concentration of 4-10 beads /cell and a volume of 4 ml supplemented D-MEM. The cell- 
beads mixtures were placed in a sterile 15 ml centrifuge tube (Fisherbrand, Florence, KY) and 
gently shaken overnight at room temperature. The cell-beads mixtures were then placed in 
a magnet (Dynal MPC-10) for 60 seconds to recover the STRO-1 positive cells (Figure III. 1).
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The supernatant was discarded and the STRO-1 positive cells washed gently with PBS 
supplemented with BSA (100 mg/ml), pH 7.4. The cells were resuspended in 1 ml PBS and 
placed on a shaker for 5 minutes at room temperature. This washing protocol was repeated 
three times after which the cells were resuspended in supplemented D-MEM and plated at a 
density of 104 cells per 35 mm dish, in 2 ml supplemented D-MEM. The cells were incubated 
in a humidified incubator at 37°C and 5% CO2.
Alkaline phosphatase activity.
Differentiation of osteoprogenitors was assessed using cytochemistry for alkaline 
phosphatase according to Narisawa et al. (1990). Isolated and cultivated STRO-1 positive 
cells were fixed in situ on culture days 5, 8, 10 and 14 with 10% formalin in PBS for 10 
minutes at 4°C. The cells were then washed twice with 0.2 M Tris buffer, pH 8.9. The 
reaction mixture, prepared fresh, consisted of 0.1 % naphtol-AS-MX phosphate and 0.3 % 
fast violet B salt in 0.1 M Tris buffer, pH 8.9. All reagents were purchased from Sigma, St 
Louis, MO. The fixed cells were incubated in presence of the reaction mixture for 30-40
minutes at 37°C. Following incubation, they were washed with distilled H2O, viewed under 
a bright field microscope (IMT-2 Olympus microscope) and the number of cells positive for 
alkaline phosphatase counted.
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Figure ULl. Schematic illustration of the immunomagnetic protocol
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Immunofluorescence'.
STRO-1 positive cells were cultivated for 21 days and assayed in situ for the 
expression of osteocalcin. The cell culture medium was removed and the cells washed briefly 
with PBS. The cells were fixed in 4% paraformaldehyde in PBS (pH 7.2) for 10 minutes at 
room temperature. After two washes with PBS, the cells were incubated for 20 minutes in 
1% horse serum in PBS, then they were exposed for 1 hour to a 1/500 dilution of a mouse 
anti-human osteocalcin MAb (Takara Biomedicals, Japan). Following incubation and two 
washes with PBS, the cells were incubated with the second antibody (fluorescein anti-mouse 
IgG, Vector Laboratories, Burlingame, CA) for 1 hour at room temperature in the dark. After 
two washes with PBS, the cells were visualized with a fluorescence microscope (BH-2 
Olympus biological fluorescence microscope). As anegative control, the human breast cancer 
cell line, MDA-231, was assayed for the expression of osteocalcin.
Reverse transcriptase-polymerase chain reaction
Total RNA was extracted from freshly isolated STRO-1 positive cells, and from 
STRO- 1 positive cells after 21 days of culture. We used RNAzol reagent and the protocol 
provided by the manufacturer (Tel-Test, Friendswood, TX). Total RNA samples were treated 
with RNase-free DNase (Promega, Madison, WI) to eliminate any genomic DNA present. 
Single-strand cDNA was obtained after reverse transcription of 1 pg of total RNA using 
oligo-dT primers and Superscript II reverse transcriptase (Gibco, Grand Island, NY). Two 
pi of the resulting cDNA were selectively amplified for 40 cycles (94°C for 1 min, 60°C for
1 min, 72°C for 2 min) with primers specific for mouse and human Cbfa-1, and human
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osteocalcin. The primers selected for Cbfa-1 were(5'-GAGGGCACAAGTTCTATCTGGA-3'
forward sequence) and (5-GGTGGTCCGCGATGATCTC-31 reverse complement). These 
primers were chosen according to Ducy et and Geoffroy et al. (1998). The
resulting PCR fragment is 336 bp long. The primers selected for human osteocalcin were 
devised according to the sequence reported by Celeste et al., (1986). They were (5- 
GCCCTCACACTCCTCGCCC-3' forward sequence) and (5'-CACACACCTCCCTCCTGG-
3' reverse complement). The resulting PCR product is a fragment of 206 bp. As negative 
controls, we performed PCR onRT reaction products obtained without reverse transcriptase.
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RESULTS
Following purification, osteoprogenitors were plated and monitored for differentiation 
and/or proliferation. Interestingly, human osteoprogenitors remained in isolation and did not 
develop into clusters or colonies of cells (Figure III.2). Moreover, they seemed to remain 
quiescent for a period of 8-10 days before any activity was recorded. Instead of proliferating 
into colonies, human osteoprogenitors spread and assumed the osteoblastic morphology prior 
to undergoing cell division (Figure III.3). This characteristic pattern of differentiation 
originated at individual cells then spread from the central loci to other cells. Only after 
spreading and elongation was complete within clusters of 4 or more cells was any 
proliferation observed in these cultures.
Furthermore, expression of alkaline phosphatase was not detected in these cultures 
until the cells began assuming the osteoblastic phenotype. In fact, we found that achieving 
maximal expression levels of alkaline phosphatase enzyme was strikingly correlated with the
onset of division.
Upon differentiating into mature osteoblasts, proliferation ensued vigorously until 
monolayers of pure alkaline phosphatase positive osteoblasts reached confluence within 2-3 
weeks (Figure III.4). On day 21, mature osteoblasts were assayed for the presence of 
osteocalcin by immunofluorescence. Figures III.5a and c are photographs of individual
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osteoblasts taken under phase contrast microscopy following immunofluorescence. Figures 
in. 5b and d are respective photographs of the same cells under fluorescence microscopy. As 
evidenced by the photographs, osteocalcin can be found within compartments in the 
cytoplasm of differentiated STRO-1 positive cells. Figures III.5e and f are photographs of 
MDA-231 cells following immunofluorescence under phase contrast and fluorescence 
microscopy, respectively.
Results for the RT-PCR trial were inconclusive. We did not detect the presence of
either osteocalcin or Cbfa-1 mRNA within differentiated cells.
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Figure DL2. Human bone marrow STRO-1 positive cells immediately 
following isolation using immunomagnetic isolation. Yields consisted of 
100% STRO-1 antigen expressing cells. Original x800.
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Figure HL3. Alkaline phosphatase expression following human bone 
marrow STRO-1 positive cell differentiation. Cells assume a spread, 
elongated morphology and express high levels of alkaline phosphatase 
prior to proliferating. Original x300.
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Figure IIL4. Monolayers of alkaline phosphatase positive osteoblast-like 
cells (stained red) following human bone marrow STRO-1 positive cell 
differentiation. Original x300.
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bFigurein.5. Anti-osteocalcin immunofluorescence images. Images a and c 
were taken under phase-contrast microscopy of differentiated STRO-1 
positive cells after 21 days in culture. Images b and d were taken under 
fluorescence microscopy for the corresponding cells. Images e and f are of 
MDA-231 cells under phase contrast and fluorescence microscopy, 
respectively, used as a negative control. All images x 200 magnification.
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DISCUSSION
The establishment of an in vitro model system for studies on osteoprogenitors is the 
focus of this report. Previous investigations have established the expression of the STRO-1 
antigen on human bone marrow osteoprogenitors (Gronthos etal., 1994). The investigators 
demonstrated that the differentiation of STRO-1 positive human osteoprogenitor cells into 
functional osteoblasts could be assessed by monitoring their induction of alkaline phosphatase 
expression, by the production of the bone-specific protein osteocalcin, and by the formation 
of a mineralized matrix (hydroxyapatite) (Gronthos et al., 1994). However, the cultures 
obtained by their means were not pure.
In the present study, we have developed a highly efficient means for extracting and 
isolating a pure osteoprogenitor cell population from human bone marrow. By coating 
magnetic beads with the STRO-1 monoclonal antibody and by extracting the cells with a 
magnet, we have successfully established pure primary cultures of osteoprogenitors, as 100% 
of the cells isolated developed into alkaline phosphatase positive osteoblasts. Additionally, 
we have characterized the differentiation of the human osteoprogenitor cell by monitoring its 
progressive expression of alkaline phosphatase down the osteogenic lineage and by 
confirming their identity through the expression of osteocalcin among mature STRO-1
positive cells.
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Our observations show that human bone marrow osteoprogenitors are small, round 
cells that have already been committed to the osteogenic lineage. Moreover, human 
osteoprogenitors begin to express low levels of alkaline phosphatase en route to becoming 
mature osteoblasts. We found that these osteoprogenitor cell cultures must first differentiate 
into alkaline phosphatase positive osteoblasts prior to undergoing cell division. In fact, 
maximal levels of alkaline phosphatase were concomitant with the onset of proliferation. Our 
observations and those made recently by Hicok et al (1998) are in agreement with this 
finding. However, these results conflict with previous studies by Long et al. (1995) which 
state that human osteoprogenitors are highly proliferative cells which form clusters and 
colonies consisting of >50 cells prior to differentiating.
The finding that osteoprogenitor differentiation originates at distinct loci and then 
spreads out towards neighboring cells indicates that once one osteoprogenitor cell initiates 
differentiation into the osteoblast-like morphology, it may begin to secrete paracrine factors 
which induce other osteoprogenitor cells to follow. Our results indicate that a likely candidate 
would be osteocalcin since this protein is expressed by osteoblasts only and is locally secreted
into the immediate environment. However, further studies must be conducted in order to 
determine which other factor(s) might be responsible for inducing this paracrine-associated 
differentiation response.
Unfortunately, RT-PCR did not yield expected results for the expression of 
osteocalcin or Cbfa-1 RNA within mature STRO-1 positive cells. The fact that the 
osteocalcin protein was detected within mature STRO-1 positive cells would imply that its 
respective RNA should also be found within the cells. This leads us to believe that the
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conditions under which the RT-PCR was conducted were not optimal for our assay. Further 
modifications are required in order to develop an ideal system by which to run the reaction.
Recent investigations have revealed many of the molecular mechanisms involved in 
regulating the functional and structural properties of bone yet, with every question answered, 
many more arise. A major limitation to such investigations has been the difficulty in 
identifying a homogeneous and unambiguous population of osteoprogenitor cells that can 
readily be purified and induced to differentiate. We report an efficient means for overcoming 
such limitations. Ultimately, it would be necessary to determine how tissue development, 
mechanical input, cellular response, and the material properties of the tissue are organized in 
space, time, and function in order to maintain bone homeostasis. Such fundamental obscurities 
require further clarification before a truly comprehensive understanding of bone can be
achieved.
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CHAPTER IV
CONCLUSION
Bone is a mechanically optimized organ system whose evolution reflects the 
functional demands placed upon it. Although it serves as a structural framework, bone is 
far from being an inert substance. On the contrary, bone tissue plays essential roles as a 
hematopoietic factory and as a mediator of mineral homeostasis. Furthermore, unlike any 
other composite tissue or organ system, bone is constantly being broken down, modified, and 
rebuilt in a process known as remodeling. This process is regulated and maintained by 
various external and internal signals, including signals from the central nervous system. 
Considering the prolific nature of osteoprogenitors, it is not surprising to learn that this stem 
cell mediates the early stages of bone remodeling. Osteoprogenitors must do so on a 
continual basis since bone is constantly being broken down and rebuilt. The general 
mechanisms by which this occurs are similar for all mammals. However, as we have shown, 
there are, in fact, some distinct species-specific differences with respect to osteoprogenitor 
behavior. Although a number of reservations remain in the field about whether the human 
osteoprogenitor expresses the STRO-1 antigen, we have shown that this is indeed the case.
In our studies, 100% of the STRO-1+ fraction of the human bone marrow exhibited the
characteristics expected of osteoblast precursors. Yet, we did not detect the antigen on
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murine osteoprogenitors. This implies that some fundamental genetic diversities exist 
between the two species. Additionally, we have shown that murine osteoprogenitors are 
highly proliferative cells which form clusters then colonies of 50 or more clones before they 
undergo differentiation. In fact, such cellular progression underlies a long accepted dogma 
of cell biology which dictates that cells proliferate then differentiate. In humans, this is not 
so. Our results indicate that human osteoprogenitors are not conspicuously proliferative, but 
rather, supply the bone-forming machinery by first differentiating into alkaline phosphatase 
positive preosteoblasts and then proliferating into monolayers of functional osteoblasts. 
Recently, Hicok et al. (1998) published an article stating that the sequence of rat osteoblast 
differentiation differs significantly from the sequence observed in human bone marrow stromal 
cells, suggesting that important species differences exist. Their findings lend support to our 
observations on the species-specific characteristics of osteoblast differentiation.
In summary, we have succeeded in extracting, culturing, and characterizing the cells 
which represent the three distinct stages of osteogenesis. We have also developed a highly 
efficient means for purifying human bone marrow osteoprogenitor cells by using 
immunomagnetic isolation. Furthermore, we have characterized these cells and have 
conclusively proven the expression of the STRO-1 antigen on human bone marrow 
osteoprogenitors.
Although extensive studies have been conducted on the stimulation and signal 
transduction pathways associated with bone remodeling, much remains to be determined 
before a truly comprehensive understanding can be achieved. Thus far, it is well accepted 
that the complexities of remodeling occur through several general phases including
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quiescence, activation, resorption, reversal, and formation. Recent investigations have 
revealed many of the molecular mechanisms involved in regulating the functional and 
structural properties of bone yet, with every question answered, many more arise. Ultimately, 
it would be necessary to determine how tissue development, mechanical input, cellular 
response, and the material properties of the tissue are organized in space, time, and function
in order to maintain bone homeostasis. Further clarification of such fundamental obscurities
would inevitably result in the advancement of therapeutic techniques for crippling bone 
diseases such as osteoporosis and for the loss of bone integrity due to disuse, such as that 
experienced in hypogravity environments. Additionally, a better understanding of the 
molecular mechanisms for bone regeneration would substantially enhance and accelerate bone
repair in the future.
In order to facilitate the investigations on osteogenesis, we have also endeavored to 
establish a conditionally immortalized human osteoprogenitor cell line. We attempted to do 
so with the ecdysone-inducible expression system developed by No et al. (1996). We have 
prepared a plasmid construct (pIND/LTAg) that contains the SV40 Large T antigen (LTAg) 
gene (Hofmann et al., 1992) which is transcribed upon activation of an ecdysone response 
element (E/GRE) by a heterodimeric receptor. Ecdysone is an insect-specific steroid 
hormone which induces molting and metamorphosis by influencing chromosomal puffing. A 
benefit for transferring ecdysone responsiveness to mammalian cells is that it takes advantage 
of a naturally evolved steroid-inducible system whose lipophilic compounds enable efficient 
penetration into all tissues (No et al., 1996). Ecdysteroids have short half-lives and favorable 
pharmacokinetics which expedite clearance and prevent storage. Additionally, they are
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neither toxic, teratogenic, nor known to affect mammalian physiology. These characteristics
make them ideal candidates for utilization in the conditional immortalization of human
osteoprogenitors.
The pIND/LTAg plasmid was successfully constructed. All evaluations indicated that
the plasmid should function according to expectations. However, co-transfection of human 
bone marrow STRO-1 positive cells were not successful by either calcium phosphate 
precipitation or electroporation. Calcium phosphate precipitation proved much too stressful 
for the delicate bone marrow stem cells. Calcium phosphate exposure was varied in order to 
limit its toxicity to the cells however even the minimal incubation time induced cell death.
Although electroporation did not kill the stem cells directly, it became obvious that 
the technique was too invasive for the cells to handle. Unlike the STRO-1 positive cells 
which were not electroporated, those which were shocked did not differentiate or proliferate 
following transfection. As reported in chapter III, immunomagnetically isolated STRO-1 
positive cells began to differentiate and proliferate after 8-10 days in culture. Electroporated 
cells would neither differentiate nor proliferate but rather, would enter the Go stage of the cell 
cycle indefinitely.
We have determined that the difficulty in immortalizing the STRO-1 positive cells can 
be attributed to their stem cell characteristics. To begin with, the STRO-1 positive cell 
fraction of the bone marrow accounts for only 1 in 100,000 cells. Such low cell numbers 
decrease the success rate for plasmid introduction. Furthermore, being stem cells, STRO-1 
positive cells are extremely fragile cells which do not respond very well to the techniques 
employed in immortalization. Additionally, as evidenced by their slow growth rate following
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isolation, STRO-1 positive bone marrow stem cells display low levels of DNA replication 
which further complicate the introduction of the plasmid constructs into the genomes. Finally, 
not only is single transfection of stem cells difficult but, co-transfection dramatically decreases 
the probability that immortalization will be successful.
Essentially, the odds against co-transfection were substantial however we determined 
that the benefits in producing a conditionally immortalized STRO-1 positive stem cell line 
outweighed the risks associated with the challenge. Recently, there has been a growing 
interest in using marrow stromal cells as vehicles for both gene and cell therapy. Implanted 
marrow stromal cells into poorly healing bone could possibly enhance the repair process 
(Prockop, 1997). Marrow stromal cells locally injected were shown to promote repair of 
surgical incisions in rabbit knee cartilage, and cells in ceramic beads were shown to promote 
bone healing in an animal model (Caplan et al., 1994). Furthermore, introducing genes for 
secreted proteins into stem cells and then infusing the cells systemically so that they return to 
the marrow and secrete the therapeutic protein is another possible application for a 
conditionally immortalized stem cell line. Alternatively, one could encapsulate cells secreting 
a therapeutic protein into some inert material that allows diffusion of the proteins but not the 
cells themselves (Prockop, 1997). An additional application is to infuse the conditionally 
immortalized cell line systemically under conditions in which the cells will not only repopulate 
bone marrow, but will also give rise to progeny for the repopulation of other tissue such as 
lung, bone, cartilage, and perhaps even brain (Pereira et al., 1996).
Ultimately, the benefits for a conditionally immortalized osteoprogenitor cell line 
continue beyond the scope of this report. However, of particular importance for developing
58
conditionally immortalized cell lines is the fact that they can be induced to proliferate and 
expand in culture yet, upon administration into the human body, would behave as normal cells 
do naturally. This would limit the complications that could arise from such therapeutic
procedures.
A significant portion of our research focused on stem cell biology. Stem cells are 
notorious for being difficult to isolate and cultivate. Such characteristics are at the basis for 
why, even though interests are high, there remains a very low number of researchers which 
specialize in stem cell investigations. However, we hope that studies such as this one will 
ultimately help advance the studies on such cells for they lie at the foundation of most 
developmental processes. Establishing a thorough understanding of their properties and 
functions will eventually lead to quicker, more efficient, and less invasive therapeutic 
techniques which will better the conditions of not only bone repair, but human healthcare in 
general.
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